Korolczuk A et al. |
The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity. |
2014 |
J. Physiol. Pharmacol. |
pmid:25554991
|
Korbecki J et al. |
Cyclooxygenase pathways. |
2014 |
Acta Biochim. Pol. |
pmid:25343148
|
Savinainen JR et al. |
Robust hydrolysis of prostaglandin glycerol esters by human monoacylglycerol lipase (MAGL). |
2014 |
Mol. Pharmacol. |
pmid:25140003
|
Wasinger C et al. |
Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells. |
2014 |
Br. J. Pharmacol. |
pmid:25091578
|
Mantel A et al. |
Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism. |
2014 |
Exp. Dermatol. |
pmid:24917395
|
Tang J et al. |
Aspirin treatment improved mesenchymal stem cell immunomodulatory properties via the 15d-PGJ2/PPARγ/TGF-β1 pathway. |
2014 |
Stem Cells Dev. |
pmid:24730450
|
Koyani CN et al. |
15-deoxy-Δ¹²,¹â´-PGJâ‚‚ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis. |
2014 |
Int. J. Cardiol. |
pmid:24698234
|
Yen CC et al. |
Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. |
2014 |
Oncotarget |
pmid:24566468
|
Wang C et al. |
A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles. |
2014 |
Nat. Methods |
pmid:24292485
|
Olsen KC et al. |
Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules. |
2014 |
Am. J. Respir. Cell Mol. Biol. |
pmid:24175906
|
GarcÃa-Bueno B et al. |
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. |
2014 |
Schizophr Bull |
pmid:23486748
|
Kumar AP et al. |
Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinoma. |
2014 |
Antioxid. Redox Signal. |
pmid:23964924
|
Katsumata Y et al. |
Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2. |
2014 |
Hypertension |
pmid:24101662
|
Tachi M et al. |
Mass spectrometric determination of prostanoids in rat hypothalamic paraventricular nucleus microdialysates. |
2014 |
Auton Neurosci |
pmid:24447364
|
Kurtz M et al. |
Peroxisome proliferator-activated receptor ligands regulate lipid content, metabolism, and composition in fetal lungs of diabetic rats. |
2014 |
J. Endocrinol. |
pmid:24389592
|
Jung WK et al. |
The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells. |
2014 |
Int. J. Mol. Med. |
pmid:24337644
|
Kang ES et al. |
15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells. |
2014 |
Free Radic. Res. |
pmid:24180671
|
Nozaki Y et al. |
PPARγ ligand attenuates portal inflammation in the MRL-lpr mouse: a new strategy to restrain cholangiopathy in primary biliary cirrhosis. |
2013 |
Med Mol Morphol |
pmid:23397546
|
Doyle MC et al. |
15-Deoxy-Δ(12,14)-prostaglandin J2 inhibits IL-13 production in T cells via an NF-κB-dependent mechanism. |
2013 |
Biochem. Biophys. Res. Commun. |
pmid:23333326
|
Sykes L et al. |
The CRTH2 agonist Pyl A prevents lipopolysaccharide-induced fetal death but induces preterm labour. |
2013 |
Immunology |
pmid:23374103
|